ロード中...
By-Products of Heparin Production Provide a Diverse Source of Heparin-like and Heparan Sulfate Glycosaminoglycans
Global production of pharmaceutical heparin (Hp) is increasing, and the production process from raw mucosal material results in large amounts of waste by-products. These contain lower sulfated Hp-like and heparan sulfate (HS), as well as other glycosaminoglycans, which are bioactive entities with ph...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6389988/ https://ncbi.nlm.nih.gov/pubmed/30804383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-39093-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|